期刊文献+

我国静脉用药现状与监管措施系统分析

Current Management of Intravenous Medications in China
下载PDF
导出
摘要 分析我国静脉用药现状和存在问题,结合国内外管理策略和应用指南,提出改善我国静脉用药现状的措施。通过建立有效的监管机制、制定统一的指导原则、落实静脉用药准则、强化人员工作职能、完善人员培训教育等方面加强静脉用药监管,限制静脉输液过度使用、降低不合理用药现象,保障全民用药健康安全。 According to the management methods and guidelines at home and abroad,the status quo of and potential problems with intravenous medications in China were analyzed while strategies to tighten the control of intravenous infusion were recommended:such as the establishment of an effective supervision mechanism,formulation of uniform guidelines,implementation of norms for intravenous drugs,strengthening of personnel functions,and upgrading of personnel training in order to curb the overuse of intravenous infusion,reduce irrational drug use,and ensure the health and safety of patients in China.
作者 文爱东 张迪 张娟利 樊婷婷 丁莉坤 任丹君 刘美佑 王婧雯 WEN Ai-dong;ZHANG Di;ZHANG Juan-li;FAN Ting-ting;DING Li-kun;REN Dan-jun;LIU Mei-you;WANG Jing-wen(The First Affiliated Hospital of Air Force Medical University,Xi'an 710032,China)
出处 《解放军药学学报》 CAS 2024年第2期95-99,共5页 Pharmaceutical Journal of Chinese People's Liberation Army
关键词 静脉用药 药品不良事件 合理用药 静脉用药监管措施 intravenous infusion adverse drug event rational drug use intravenous infusion management measure
  • 相关文献

参考文献10

二级参考文献84

共引文献109

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部